Citius Oncology Inc. (CTOR)
CTOR trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7920
-2.54% on the day
Market cap
$73.6M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CTOR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001851484 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-08-14 |
| Latest annual report ANNUAL REPORT | 10-K | 2025-12-23 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-29 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-08-26 |
Source: SEC EDGAR submissions feed, 265 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
| HRTX | Heron Therapeutics Inc. | $0.3906 | -6.01% | $74.2M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
| ACRV | Acrivon Therapeutics Inc. | $1.75 | -7.89% | $75.0M |
| INCR | Intercure Ltd. | $5.03 | +1.62% | $75.5M |
| MAIA | MAIA Biotechnology Inc. | $1.16 | -1.70% | $71.6M |
| NTHI | NeOnc Technologies Holdings Inc. | $2.60 | -4.95% | $77.2M |
| ZYBT | Zhengye Biotechnology Holding Limited | $1.48 | -12.43% | $70.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier